Comparative safety analysis of Riluzole, Edaravone and Tofersen in ALS management: insights from FAERS database
{{output}}
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. Riluzole, Edaravone, and Tofersen, three promising treatments, have distinct profiles that merit comparative analysis to guide clinical ... ...
